VICKS COUGH FLUIDIFIER*FL 180ML

Vicks Cough Expectorant 200 mg/15 ml Syrup
Guaifenesin

What it is and what it is used for
Vicks Cough Expectorant contains the active ingredient guaifenesin, which belongs to the group of medicines called expectorants, capable of thinning and facilitating the expulsion of secretions from the bronchial system. Vicks Cough Expectorant is indicated as an expectorant in acute and chronic conditions of the bronchial system.
Consult your doctor if you do not feel better or if you feel worse after 7 days.

What you need to know before taking the medicine
Do not take Vicks Cough Expectorant
- if you are allergic to the active substance or any of the other ingredients of this medicine (listed in section 6);

Warnings and precautions
Talk to your doctor or pharmacist before taking Vicks Cough Expectorant.
Pay particular attention and ask your doctor for advice before taking Vicks Cough Expectorant if you have a chronic or persistent cough, such as that caused by asthma, smoking, chronic bronchitis, and a lung disease called emphysema.
If you need to undergo laboratory tests to determine levels of 5-hydroxyindoleacetic acid and vanillylmandelic acid. Vicks Cough Expectorant may cause a false positive result. Consult your doctor if symptoms persist for more than 7 days or if the disorder recurs repeatedly or if you have noticed any recent change in its characteristics.

Children
Vicks Cough Expectorant is not recommended for children under 2 years of age unless deemed strictly necessary by the doctor.

Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Rarely, side effects affecting predominantly the stomach and intestines such as nausea, vomiting, and diarrhoea may occur.
In subjects allergic to the components of the medicine, itching, redness, and skin rash may occur.

Reporting of side effects
If you get any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects, you can help provide more information on the safety of this medicine.